Skip to content

Antibody Screening for Anti-Cardiolipin Antibodies (IgG, IgM)

Published: August 9, 2026Updated: August 16, 2026

This test measures the presence of antibodies in your blood that target cardiolipin, a fatty substance found in cell membranes. These antibodies may be linked to certain autoimmune conditions or blood clotting issues.

Quick summary

["This screening helps assess potential risks for autoimmune disorders or blood clotting problems."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
33980-4
Short code
VGCC-P/Q Bind Ab Ser-sCnc
Synonyms
VGCC-P/Q Bind Ab Ser-sCnc
Category
electrolyte
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have symptoms or risk factors for conditions like lupus, antiphospholipid syndrome, or other autoimmune diseases. It may also be checked during evaluations for unexplained blood clots, recurrent miscarriages, or other unexplained health concerns.

What to Expect Before the Test

No special preparation is needed. You may have a blood sample drawn from a vein in your arm. If you’re on blood thinners, let your provider know before the test.

What the Test Results Mean

The test detects antibodies (IgG and IgM) that target cardiolipin, a component found in cell membranes. Elevated levels may indicate an autoimmune response, but results alone don’t diagnose a condition. Results are often interpreted alongside other tests and symptoms.

Common Conditions Linked to Positive Results

Positive results may be associated with autoimmune diseases like lupus, antiphospholipid syndrome, or other conditions affecting blood clotting. However, some people test positive without symptoms.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Antibodies to cardiolipin can be part of an autoimmune response, where the body mistakenly attacks healthy cells. High levels may increase the risk of blood clots, miscarriages, or other complications. However, many people with positive results have no symptoms. Your provider will consider the context (symptoms, other tests) to guide further action.

Short name

Anti-Cardiolipin Antibodies (IgG/IgM) Screen

Frequently asked questions

What does a positive result mean for me?
A positive result means your body detected cardiolipin antibodies, which may suggest an autoimmune or clotting-related concern. Your provider will discuss next steps, such as further testing or monitoring, based on your symptoms and overall health.
Can I take anything before this test?
No special preparation is needed. However, if you’re on blood thinners (like warfarin), let your provider know before the test to avoid unnecessary delays or risks.
Will this test be repeated if my results are abnormal?
Yes, your provider may repeat the test or order additional tests (like confirmation assays) to clarify results. They may also check other markers or symptoms to understand your condition better.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy